Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6886 to 6900 of 7707 results

  1. Acute bowel obstruction

    Discontinued [GID-NG10377]

  2. Endometriosis: diagnosis and management - surgical management - pain management post-surgery

    Discontinued [GID-NG10385]

  3. Breathlessness

    Discontinued [GID-NG10387]

  4. Atopic Dermatitis (Eczema)

    Discontinued [GID-NG10289]

  5. Lenadogene nolparvovec for treating Leber's hereditary optic neuropathy caused by the G11778A ND4 mitochondrial mutation [ID1410]

    In development [GID-TA10391] Expected publication date: TBC

  6. Surgical site infections: prevention and treatment - Update

    Discontinued [GID-NG10374]

  7. Type 2 diabetes in adults: management - insulin therapy

    Discontinued [GID-NG10375]

  8. Nivolumab for neoadjuvant and adjuvant treatment of localised renal cell carcinoma [ID4047]

    Discontinued [GID-TA10927]

  9. Pegcetacoplan for amyotrophic lateral sclerosis TS ID 10594

    In development [GID-TA11310] Expected publication date: TBC

  10. Zio Service for detecting cardiac arrhythmias (MIB101)

    This advice has been updated and replaced by NICE medical technologies guidance 52.

  11. PneuX for preventing ventilator-associated pneumonia in intensive care (MIB45)

    This advice has been updated and replaced by NICE medical technologies guidance 48.

  12. Absorb Bioresorbable Vascular Scaffold system for coronary artery disease (MIB84)

    NICE withdrew this medtech innovation briefing in November 2017 after the company stopped manufacturing Absorb because of low uptake. Some UK hospitals continue to use the technology in ongoing clinical studies.

  13. Alcohol: school-based interventions (PH7)

    This guideline has been updated and replaced by NICE guideline NG135.

  14. Physical activity and the environment (PH8)

    This guideline has been updated and replaced by NICE guideline NG90.